Pelvic Organ Prolapse Market by Treatment Modalities {Surgical [Cystocele Repair, Hysterectomy, Rectocele Repair, Vaginal Vault Suspension, Vaginal Obliteration, Others], Non-surgical [Pessaries, Myofascial Release Therapy (MFR) (Direct MFR, Indirect MFR), Other Physical Exercises]}; by Surgical Approach {Abdominal Approach, Laparoscopic, Vaginal Approach, Robotic, Others}; by Type {Cystocele, Enterocele, Rectocele, Uterine Prolapse, Vaginal Vault Prolapse, Uterine Prolapse, Others};


Report ID : RNR-203839 Category : Pharma Healthcare Published Date : 2018
Publisher : Research-N-Reports Pages : 125 Format : PDF
Pelvic organ prolapse occurs when a pelvic organ-such as the bladder-drops (prolapses) from its normal place in the lower belly and pushes against the walls of the vagina. This happens when the muscles that hold the pelvic organs in place get weak or stretched from childbirth or surgery. Situations like childbirth, chronic cough, obesity or hormonal changes can cause the organs held in place by the pelvic floor to drop; this condition is also known as prolapse. In terms of revenue, the Global Pelvic Organ Prolapse Market is anticipated to be valued at US$ 24.03 Bn in 2017 and is expected to reach US$ 32.41 Bn by 2025, expanding at a CAGR of 4.3% from 2017 to 2025.
The Global Pelvic Organ Prolapse Market is enhanced by factors such as:
•	Introduction of novel therapies.
•	Rising demand for effective therapies among patients.
•	Increasing prevalence of the condition.
Based on treatment modalities, the Global Pelvic Organ Prolapse Market is classified into surgical and non-surgical treatment. Out of these segments, the non-surgical segment dominated the global market in the previous years and is projected to maintain its dominance during the forecast period.
On the basis of surgical approach, the global market is segmented into abdominal approach, laparoscopic, vaginal approach, robotic and others. Of these, the abdominal approach segment is anticipated to witness the fastest growth over the forecast period. Factors responsible for its greater market share may be classified into rising number of centers, development of training courses, and rising number of patients requiring pelvic organ prolapse treatment.
The Global Pelvic Organ Prolapse Market is divided into cystocele, enterocele, rectocele, uterine prolapse, vaginal vault prolapse, uterine prolapse and others based on the type of pelvic organ prolapse. The cystocele segment is anticipated to lead the global market during the conjecture period. Cystocele is a prolapse of the bladder into the front wall of the vagina.
Among the area of occurrence segments, the anterior compartment segment dominated the global market in 2016 and is anticipated to continue its dominance over the forecast period as well.
Geographically, North America dominates the Global Pelvic Organ Prolapse Market. Pelvic organ prolapse is a serious disease in the U.S., which affects nearly 1,000,000 women each year and 25% of women are admitted to the hospital for treatment. Europe is the second largest market for pelvic organ prolapse. Asia Pacific is expected to expand at a higher rate due to rapid population growth, growing awareness among people, increasing healthcare expenditure, and government initiatives that will drive the global market in the region. Emerging regions such as Latin America and Middle East & Africa are likely to create ample opportunities for the global market.
Some of the significant players functional in the Global Pelvic Organ Prolapse Market include Coloplast, C. R. Bard Inc., Boston Scientific Corporation, Cook Group Incorporated, CooperSurgical Inc., MedGyn Products Inc, Integra LifeSciences Corporation, Panpac Medical, Medesign, Smiths Medical, Thomas Medical, Dr. Arabin GmbH & Co. KG, Bray Group, Ethicon, Boston Scientific, Neomedic, Al-Zahrawi Medical Supplies, Kalium Group and so on.
1. Introduction 
1.1. Market Scope 
1.2. Market Segmentation 
1.3. Methodology 
1.4. Assumptions 
2. Pelvic Organ Prolapse Market Snapshot 
2.1. Market Dynamic Snapshot 
2.1.1. Comparative Analysis (Base year v/s. Forecast) 
2.1.2. Geographic Outlook 
3. Qualitative Analysis: Pelvic Organ Prolapse Market 
3.1. Introduction 
3.1.1. Product Definition 
3.1.2. Industry Development 
3.2. Market Dynamics 
3.2.1. Drivers 
3.2.2. Restraints 
3.2.3. Opportunities 
3.3. Cost Analysis of Surgeries for Treatment of Pelvic Organ Prolapse, by Key Countries 
3.3.1. U.S. 
3.3.2. UK 
3.3.3. Japan 
3.3.4. India 
3.3.5. China 
3.3.6. Germany 
3.4. Spending Analysis: Treatment Modalities 
3.5. Rate of Penetration, By Geography 
3.5.1. North America 
3.5.2. Europe 
3.5.3. Asia Pacific 
3.5.4. Middle East and Africa 
3.5.5. Latin America 
3.6. Rate of Treatment, By Geography 
3.6.1. North America 
3.6.2. Europe 
3.6.3. Asia Pacific 
3.6.4. Middle East and Africa 
3.6.5. Latin America 
3.7. Treatment Population, By Treatment Modalities 
3.7.1. Surgical 
3.7.1.1. Cystocele Repair 
3.7.1.2. Hysterectomy 
3.7.1.3. Rectocele Repair 
3.7.1.4. Vaginal vault suspension 
3.7.1.5. Vaginal obliteration 
3.7.1.6. Others 
3.7.2. Non-surgical 
3.7.2.1. Pessaries 
3.7.2.2. Myofascial Release Therapy (MFR) 
3.7.2.2.1. Direct MFR 
3.7.2.2.2. Indirect MFR 
3.7.3. Other Physical Exercises 
4. Global Pelvic Organ Prolapse Market Analysis and Forecasts, 2010 - 2025 
4.1. Overview 
4.2. Global Pelvic Organ Prolapse Market Revenue (US$ Mn) and Forecasts, By Treatment Modalities 
4.2.1. Overview and Definition 
4.2.2. Surgical 
4.2.2.1. Cystocele Repair 
4.2.2.2. Hysterectomy 
4.2.2.3. Rectocele Repair 
4.2.2.4. Vaginal vault suspension 
4.2.2.5. Vaginal obliteration 
4.2.2.6. Others 
4.2.3. Non-surgical 
4.2.3.1. Pessaries 
4.2.3.2. Myofascial Release Therapy (MFR) 
4.2.3.2.1. Direct MFR 
4.2.3.2.2. Indirect MFR 
4.2.3.3. Other Physical Exercises 
4.3. Key Segment for Channeling Investments 
4.3.1. By Treatment Modalities 
5. Global Pelvic Organ Prolapse Market Analysis and Forecasts, 2010 - 2025 
5.1. Overview 
5.2. Global Pelvic Organ Prolapse Market Revenue (US$ Mn) and Forecasts, By Surgical Approach 
5.2.1. Overview and Definition 
5.2.2. Abdominal approach 
5.2.3. Laparoscopic 
5.2.4. Vaginal approach 
5.2.5. Robotic 
5.2.6. Others 
5.3. Key Segment for Channeling Investments 
5.3.1. By Surgical Approach 
6. Global Pelvic Organ Prolapse Market Analysis and Forecasts, 2010 - 2025 
6.1. Overview 
6.2. Global Pelvic Organ Prolapse Market Revenue (US$ Mn) and Forecasts, By Type 
6.2.1. Overview and Definition 
6.2.2. Cystocele 
6.2.3. Enterocele 
6.2.4. Rectocele 
6.2.5. Uterine Prolapse 
6.2.6. Vaginal Vault Prolapse 
6.2.7. Uterine Prolapse 
6.2.8. Others 
6.3.  Key Segment for Channeling Investments 
6.3.1. By Type 
7. Global Pelvic Organ Prolapse Market Analysis and Forecasts, 2010 - 2025 
7.1. Overview 
7.2. Global Pelvic Organ Prolapse Market Revenue (US$ Mn) and Forecasts, By Area of Occurrence 
7.2.1. Overview and Definition 
7.2.2. Anterior Compartment 
7.2.3. Posterior Compartment 
7.2.4. Apical Compartment 
7.3.  Key Segment for Channeling Investments 
7.3.1. By Area of Occurrence 
 	 
8. North America Pelvic Organ Prolapse Market Analysis and Forecasts, 2010 - 2025 
8.1. Overview 
8.2. North America Pelvic Organ Prolapse Market Revenue (US$ Mn) and Forecasts, By Treatment 
Modalities 
8.2.1. Surgical 
8.2.1.1. Cystocele Repair 
8.2.1.2. Hysterectomy 
8.2.1.3. Rectocele Repair 
8.2.1.4. Vaginal vault suspension 
8.2.1.5. Vaginal obliteration 
8.2.1.6. Others 
8.2.2. Non-surgical 
8.2.2.1. Pessaries 
8.2.2.2. Myofascial Release Therapy (MFR) 
8.2.2.2.1. Direct MFR 
8.2.2.2.2. Indirect MFR 
8.2.2.3. Other Physical Exercises 
8.3. North America Pelvic Organ Prolapse Market Revenue (US$ Mn) and Forecasts, By Surgical Approach 
8.3.1. Abdominal approach 
8.3.2. Laparoscopic 
8.3.3. Vaginal approach 
8.3.4. Robotic 
8.3.5. Others 
8.4. North America Pelvic Organ Prolapse Market Revenue (US$ Mn) and Forecasts, By Type 
8.4.1. Cystocele 
8.4.2. Enterocele 
8.4.3. Rectocele 
8.4.4. Uterine Prolapse 
8.4.5. Vaginal Vault Prolapse 
8.4.6. Uterine Prolapse 
8.4.7. Others 
8.5. North America Pelvic Organ Prolapse Market Revenue (US$ Mn) and Forecasts, By Area of Occurrence 
8.5.1. Anterior Compartment 
8.5.2. Posterior Compartment 
8.5.3. Apical Compartment 
8.6. North America Pelvic Organ Prolapse Market Revenue (US$ Mn) and Forecasts, By Country 
8.6.1. U.S. 
8.6.2. Rest of North America 
8.7. Key Segment for Channeling Investments 
8.7.1. By Country 
8.7.2. By Treatment Modalities 
8.7.3. By Surgical Approach 
8.7.4. By Type 
8.7.5. By Area of Occurrence 
9. Europe Pelvic Organ Prolapse Market Analysis and Forecasts, 2010 - 2025 9.1. Overview 
9.2. Europe Pelvic Organ Prolapse Market Revenue (US$ Mn) and Forecasts, By Treatment Modalities 
9.2.1. Surgical 
9.2.1.1. Cystocele Repair 
9.2.1.2. Hysterectomy 
9.2.1.3. Rectocele Repair 
9.2.1.4. Vaginal vault suspension 
9.2.1.5. Vaginal obliteration 
9.2.1.6. Others 
9.2.2. Non-surgical 
9.2.2.1. Pessaries 
9.2.2.2. Myofascial Release Therapy (MFR) 
9.2.2.2.1. Direct MFR 
9.2.2.2.2. Indirect MFR 
9.2.2.3. Other Physical Exercises 
9.3. Europe Pelvic Organ Prolapse Market Revenue (US$ Mn) and Forecasts, By Surgical Approach 
9.3.1. Abdominal approach 
9.3.2. Laparoscopic 
9.3.3. Vaginal approach 
9.3.4. Robotic 
9.3.5. Others 
9.4. Europe Pelvic Organ Prolapse Market Revenue (US$ Mn) and Forecasts, By Type 
9.4.1. Cystocele 
9.4.2. Enterocele 
9.4.3. Rectocele 
9.4.4. Uterine Prolapse 
9.4.5. Vaginal Vault Prolapse 
9.4.6. Uterine Prolapse 
9.4.7. Others 
9.5. Europe Pelvic Organ Prolapse Market Revenue (US$ Mn) and Forecasts, By Area of Occurrence 
9.5.1. Anterior Compartment 
9.5.2. Posterior Compartment 
9.5.3. Apical Compartment 
9.6. Europe Pelvic Organ Prolapse Market Revenue (US$ Mn) and Forecasts, By Country 
9.6.1. France 
9.6.2. The U.K. 
9.6.3. Spain 
9.6.4. Germany 
9.6.5. Italy 
9.6.6. Rest of Europe 
9.7. Key Segment for Channeling Investments 
9.7.1. By Country 
9.7.2. By Treatment Modalities 
9.7.3. By Surgical Approach 
9.7.4. By Type 
9.7.5. By Area of Occurrence 
10. Asia Pacific Pelvic Organ Prolapse Market Analysis and Forecasts, 2010 - 2025 
10.1. Overview 
10.2. Asia Pacific Pelvic Organ Prolapse Market Revenue (US$ Mn) and Forecasts, By Treatment Modalities 
10.2.1. Surgical 
10.2.1.1. Cystocele Repair 
10.2.1.2. Hysterectomy 
10.2.1.3. Rectocele Repair 
10.2.1.4. Vaginal vault suspension 
10.2.1.5. Vaginal obliteration 
10.2.1.6. Others 
10.2.2. Non-surgical 
10.2.2.1. Pessaries 
10.2.2.2. Myofascial Release Therapy (MFR) 
10.2.2.2.1. Direct MFR 
10.2.2.2.2. Indirect MFR 
10.2.2.3. Other Physical Exercises 
10.3. Asia Pacific Pelvic Organ Prolapse Market Revenue (US$ Mn) and Forecasts, By Surgical Approach 
10.3.1. Abdominal approach 
10.3.2. Laparoscopic 
10.3.3. Vaginal approach 
10.3.4. Robotic 
10.3.5. Others 
10.4. Asia Pacific Pelvic Organ Prolapse Market Revenue (US$ Mn) and Forecasts, By Type 
10.4.1. Cystocele 
10.4.2. Enterocele 
10.4.3. Rectocele 
10.4.4. Uterine Prolapse 
10.4.5. Vaginal Vault Prolapse 
10.4.6. Uterine Prolapse 
10.4.7. Others 
10.5. Asia Pacific Pelvic Organ Prolapse Market Revenue (US$ Mn) and Forecasts, By Area of Occurrence 
10.5.1. Anterior Compartment 
10.5.2. Posterior Compartment 
10.5.3. Apical Compartment 
10.6. Asia Pacific Pelvic Organ Prolapse Market Revenue (US$ Mn) and Forecasts, By Country 
10.6.1. China 
10.6.2. Japan 
10.6.3. India 
10.6.4. Southeast Asia 
10.6.5. Rest of Asia Pacific 
10.7. Key Segment for Channeling Investments 
10.7.1. By Country 
10.7.2. By Treatment Modalities 
10.7.3. By Surgical Approach 
10.7.4. By Type 
10.7.5. By Area of Occurrence 
11. Middle East & Africa (MEA) Pelvic Organ Prolapse Market Analysis and Forecasts, 2010 - 2025 
11.1. Overview 
11.2. Middle East & Africa Pelvic Organ Prolapse Market Revenue (US$ Mn) and Forecasts, By Treatment 
Modalities 
11.2.1. Surgical 
11.2.1.1. Cystocele Repair 
11.2.1.2. Hysterectomy 
11.2.1.3. Rectocele Repair 
11.2.1.4. Vaginal vault suspension 
11.2.1.5. Vaginal obliteration 
11.2.1.6. Others 
11.2.2. Non-surgical 
11.2.2.1. Pessaries 
11.2.2.2. Myofascial Release Therapy (MFR) 
11.2.2.2.1. Direct MFR 
11.2.2.2.2. Indirect MFR 
11.2.2.3. Other Physical Exercises 
11.3. Middle East & Africa Pelvic Organ Prolapse Market Revenue (US$ Mn) and Forecasts, By Surgical 
Approach 
11.3.1. Abdominal approach 
11.3.2. Laparoscopic 
11.3.3. Vaginal approach 
11.3.4. Robotic 
11.3.5. Others 
11.4. Middle East & Africa Pelvic Organ Prolapse Market Revenue (US$ Mn) and Forecasts, By Type 
11.4.1. Cystocele 
11.4.2. Enterocele 
11.4.3. Rectocele 
11.4.4. Uterine Prolapse 
11.4.5. Vaginal Vault Prolapse 
11.4.6. Uterine Prolapse 
11.4.7. Others 
11.5. Middle East & Africa Pelvic Organ Prolapse Market Revenue (US$ Mn) and Forecasts, By Area of 
Occurrence 
11.5.1. Anterior Compartment 
11.5.2. Posterior Compartment 
11.5.3. Apical Compartment 
11.6. Middle East & Africa Pelvic Organ Prolapse Market Revenue (US$ Mn) and Forecasts, By Country 
11.6.1. GCC Countries 
11.6.2. Southern Africa 
11.6.3. Rest of MEA 
11.7. Key Segment for Channeling Investments 
11.7.1. By Country 
11.7.2. By Treatment Modalities 
11.7.3. By Surgical Approach 
11.7.4. By Type 
11.7.5. By Area of Occurrence 
12. Latin America Pelvic Organ Prolapse Market Analysis and Forecasts, 2010 - 2025 
12.1. Overview 
12.2. Latin America Pelvic Organ Prolapse Market Revenue (US$ Mn) and Forecasts, By Treatment 
Modalities 
12.2.1. Surgical 
12.2.1.1. Cystocele Repair 
12.2.1.2. Hysterectomy 
12.2.1.3. Rectocele Repair 
12.2.1.4. Vaginal vault suspension 
12.2.1.5. Vaginal obliteration 
12.2.1.6. Others 
12.2.2. Non-surgical 12.2.2.1. Pessaries 
12.2.2.2. Myofascial Release Therapy (MFR) 
12.2.2.2.1. Direct MFR 
12.2.2.2.2. Indirect MFR 
12.2.2.3. Other Physical Exercises 
12.3. Latin America Pelvic Organ Prolapse Market Revenue (US$ Mn) and Forecasts, By Surgical Approach 
12.3.1. Abdominal Approach 
12.3.2. Laparoscopic Approach 
12.3.3. Vaginal Approach 
12.3.4. Robotic Approach 
12.3.5. Others 
12.4. Latin America Pelvic Organ Prolapse Market Revenue (US$ Mn) and Forecasts, By Type 
12.4.1. Cystocele 
12.4.2. Enterocele 
12.4.3. Rectocele 
12.4.4. Uterine Prolapse 
12.4.5. Vaginal Vault Prolapse 
12.4.6. Uterine Prolapse 
12.4.7. Others 
12.5. Latin America Pelvic Organ Prolapse Market Revenue (US$ Mn) and Forecasts, By Area of Occurrence 
12.5.1. Anterior Compartment 
12.5.2. Posterior Compartment 
12.5.3. Apical Compartment 
12.6. Latin America Pelvic Organ Prolapse Market Revenue (US$ Mn) and Forecasts, By Country 
12.6.1. Brazil 
12.6.2. Rest of Latin America 
12.7. Key Segment for Channeling Investments 
12.7.1. By Country 
12.7.2. By Treatment Modalities 
12.7.3. By Surgical Approach 
12.7.4. By Type 
12.7.5. By Area of Occurrence 
13. Competitive Benchmarking 
13.1. Global Presence and Growth Strategies 
13.2. Market Share Analysis 
14. Player Profiles 
14.1. Coloplast 
14.1.1.     Company Details
14.1.2. 	Company Overview 
14.1.3. 	Key Developments 
14.1.4. 	Financial Analysis 
14.1.5. 	Key Strengths 
14.1.6. 	Key Opportunities 
14.1.7. 	Business Strategies 
14.2. C. R. Bard Inc. 
14.3. Boston Scientific Corporation 14.4. Cook Group Incorporated 
14.5. CooperSurgical Inc. 
14.6. MedGyn Products Inc 
14.7. Integra LifeSciences Corporation 
14.8. Panpac Medical 
14.9. Medesign 
14.10. Smiths Medical 
14.11. Thomas Medical 
14.12. Dr. Arabin GmbH & Co. KG 
14.13. Bray Group 
14.14. Ethicon 
14.15. Boston Scientific 
14.16. Neomedic 
14.17. Al-Zahrawi Medical Supplies 
14.18. Kalium Group 
14.19. Others 
15. Key Findings 
Note: This ToC is tentative and can be changed according to the research study conducted during the course of report completion. 
 	 
Disclaimer 
•	The request/orders received by Research N Reports provides strategic business/market analysis services to a select group of customers which are limited publications, containing valuable market information. The analysis services are meant for customers’ internal use only and not for general publication or disclosure to third parties.  
 
•	Quantitative information is real-time and is primarily based on interviews, Research N Reports does not make any warranty for the accuracy of the data and may liable to fluctuation. Also, RNR takes no responsibility for any incorrect information supplied to us by manufacturers or users. 
 
•	Without prior written permission from Research N Reports, the report or service cannot be resold, lent, disclosed, and circulated. Also, no part of this report may be reproduced, or transmitted in any form or by any means such as electronic, photocopying, mechanical, recording or otherwise without the permission of Research N Reports. 
 
•	Since we deal in the information services sector and given the sensitive nature of our industry, our customers will comprehend the no return policy. Once the data or information has been provided, we would be unable to refund the order charges and hence would request customers to get proper approvals and carefully place orders. We are always willing to help you in case of any assistance required. 
 
•	For more information regarding permission, kindly contact: sales@researchnreports.com